99 related articles for article (PubMed ID: 4245998)
1. The response of ponies to Myxovirus influenzae A-equi 2. I. Serum and nasal antibody titres following exposure.
Rouse BT; Ditchfield WJ
Can J Comp Med; 1970 Jan; 34(1):1-5. PubMed ID: 4245998
[TBL] [Abstract][Full Text] [Related]
2. The response of ponies to Myxovirus influenzae A-equi 2. II. Immunoglobulin classes of antibody to the virus in serum and nasal secretions.
Rouse BT; Ditchfield WJ
Can J Comp Med; 1970 Jan; 34(1):7-12. PubMed ID: 4192439
[TBL] [Abstract][Full Text] [Related]
3. Assessment of resistance to influenza virus infection in animal models.
Potter CW; McLaren C; Jennings R
Dev Biol Stand; 1975; 28():307-18. PubMed ID: 1126574
[TBL] [Abstract][Full Text] [Related]
4. Studies on the antigenicity of an inactivated, aluminum hydroxide adjuvant equine influenza vaccine.
Kucera CJ; Beckenhauer WH
Can J Comp Med; 1977 Jul; 41(3):326-31. PubMed ID: 20211
[TBL] [Abstract][Full Text] [Related]
5. Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge.
Breathnach CC; Clark HJ; Clark RC; Olsen CW; Townsend HG; Lunn DP
Vaccine; 2006 Feb; 24(8):1180-90. PubMed ID: 16194586
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of a whole inactivated EI vaccine against a recent EIV outbreak isolate and comparative detection of virus shedding.
Paillot R; Prowse L; Donald C; Medcalf E; Montesso F; Bryant N; Watson J; Jeggo M; Elton D; Newton R; Trail P; Barnes H
Vet Immunol Immunopathol; 2010 Aug; 136(3-4):272-83. PubMed ID: 20400185
[TBL] [Abstract][Full Text] [Related]
7. Antibody responses and resistance to challenge in volunteers vaccinated with live attenuated, detergent split and oil adjuvant A2-Hong Kong-68 (H 3 N 2 ) influenza vaccines. A report to the Medical Research Council Committee on Influenza and other Respiratory Virus Vaccines.
Freestone DS; Hamilton-Smith S; Schild GC; Buckland R; Chinn S; Tyrrell DA
J Hyg (Lond); 1972 Sep; 70(3):531-43. PubMed ID: 4506997
[TBL] [Abstract][Full Text] [Related]
8. The nasal secretion and serum antibody response of lambs following vaccination and aerosol challenge with parainfluenza 3 virus.
Smith WD
Res Vet Sci; 1975 Jul; 19(1):56-62. PubMed ID: 168628
[TBL] [Abstract][Full Text] [Related]
9. Induction of systemic and mucosal immunity and maintenance of its memory against influenza A virus by nasal vaccination using a new mucosal adjuvant SF-10 derived from pulmonary surfactant in young cynomolgus monkeys.
Mizuno D; Kimoto T; Sakai S; Takahashi E; Kim H; Kido H
Vaccine; 2016 Apr; 34(16):1881-8. PubMed ID: 26954466
[TBL] [Abstract][Full Text] [Related]
10. HL-A antigens and antibody response after influenza A vaccination. Decreased response associated with HL-A type W16.
Spencer MJ; Cherry JD; Terasaki PI
N Engl J Med; 1976 Jan; 294(1):13-6. PubMed ID: 1105178
[TBL] [Abstract][Full Text] [Related]
11. A comparison of antibody responses to commercial equine influenza vaccines following primary vaccination of Thoroughbred weanlings--a randomised blind study.
Gildea S; Arkins S; Walsh C; Cullinane A
Vaccine; 2011 Nov; 29(49):9214-23. PubMed ID: 21983355
[TBL] [Abstract][Full Text] [Related]
12. The use of a systemic prime/mucosal boost strategy with an equine influenza ISCOM vaccine to induce protective immunity in horses.
Crouch CF; Daly J; Henley W; Hannant D; Wilkins J; Francis MJ
Vet Immunol Immunopathol; 2005 Dec; 108(3-4):345-55. PubMed ID: 16098611
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulins in the serum and nasal secretions of lambs following vaccination and aerosol challenge with parainfluenza 3 virus.
Smith WD; Dawson AM; Wells PW; Burrells C
Res Vet Sci; 1976 Nov; 21(3):341-8. PubMed ID: 193171
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a commercially available modified-live Streptococcus equi subsp equi vaccine in ponies.
Borst LB; Patterson SK; Lanka S; Barger AM; Fredrickson RL; Maddox CW
Am J Vet Res; 2011 Aug; 72(8):1130-8. PubMed ID: 21801073
[TBL] [Abstract][Full Text] [Related]
15. Intranasally administered Endocine formulated 2009 pandemic influenza H1N1 vaccine induces broad specific antibody responses and confers protection in ferrets.
Maltais AK; Stittelaar KJ; Veldhuis Kroeze EJ; van Amerongen G; Dijkshoorn ML; Krestin GP; Hinkula J; Arwidsson H; Lindberg A; Osterhaus AD
Vaccine; 2014 May; 32(26):3307-15. PubMed ID: 24690149
[TBL] [Abstract][Full Text] [Related]
16. Aerosol immunization of humans with inactivated parainfluenza type 2 vaccine.
Wigley FM; Fruchtman MH; Waldman RH
N Engl J Med; 1970 Dec; 283(23):1250-3. PubMed ID: 4320010
[No Abstract] [Full Text] [Related]
17. Bordetella rhinitis in pigs: serum and nasal antibody response to Bordetella bacterins.
Brandenburg AC
Can J Comp Med; 1978 Jan; 42(1):23-8. PubMed ID: 647455
[TBL] [Abstract][Full Text] [Related]
18. Induction of Local Secretory IgA and Multifunctional CD4⁺ T-helper Cells Following Intranasal Immunization with a H5N1 Whole Inactivated Influenza Virus Vaccine in BALB/c Mice.
Trondsen M; Aqrawi LA; Zhou F; Pedersen G; Trieu MC; Zhou P; Cox RJ
Scand J Immunol; 2015 May; 81(5):305-17. PubMed ID: 25737202
[TBL] [Abstract][Full Text] [Related]
19. The production of neutralizing activity in serum and nasal secretion following immunization with influenza B virus.
Downie JC; Stuart-Harris CH
J Hyg (Lond); 1970 Jun; 68(2):233-44. PubMed ID: 5270204
[TBL] [Abstract][Full Text] [Related]
20. A comparison of subcutaneous, nasal, and combined influenza vaccination. I. Antigenicity.
Gwaltney JM; Edmondson WP; Rothenberg R; White PW
Am J Epidemiol; 1971 Jun; 93(6):472-9. PubMed ID: 5562719
[No Abstract] [Full Text] [Related]
[Next] [New Search]
